Combination Treatment With Individually Deep Brain Reorienting (DBR) Processing and Group Intervention for People With Complex Dissociative Disorder
Integrating Individual Deep Brain Reorienting With a Supportive Group Intervention for Complex Dissociative Disorders: A 16-Week Feasibility and Pilot Study
1 other identifier
interventional
10
1 country
1
Brief Summary
The goal of this pilot clinical trial is to learn whether an integrated 16-week treatment program can be helpful, acceptable, and feasible for adults with complex dissociative disorder (CDD). The program combines individual Deep Brain Reorienting (DBR) therapy with a supportive therapeutic group. The study is conducted at an outpatient clinic for traume-related disorders in Oslo, Norway, and enrols individuals based on rights to receive specialist treatment in the Norwegian public health system. The main questions it aims to answer are: Is it possible to recruit, retain, and treat patients with CDD in this program (feasibility, attendance, drop-out, and treatment tolerability)? How do participants experience receiving DBR together with a supportive group (helpfulness, burden, and suggestions for improvement)? Are there preliminary changes in symptoms, functioning, and quality of life from before to after treatment and at 6-month follow-up? Are two new DBR-specific questionnaires (Where Self Awareness Scale and Shock Induced Vigilance Scale) useful for this patient group? There is no comparison group in this pilot study. All participants receive the same integrated DBR + group intervention. Participants will:
- Take part in two preparatory individual sessions to receive information about DBR, try the method, and clarify treatment goals.
- Attend a 16-week program with one 45-minute individual DBR session per week and two 30-minute online group sessions per week.
- Join in-person group meetings before the program and a focus group meeting at the end to talk about what was helpful and what could be improved.
- Complete standard questionnaires about trauma-related symptoms before and after treatment, as well as two brief DBR-specific questionnaires at several time points.
- Take part in group interviews right after treatment and 6 months later, and have an individual closing session to summarize their experiences and discuss next steps.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 4, 2026
CompletedFirst Submitted
Initial submission to the registry
June 24, 2026
CompletedFirst Posted
Study publicly available on registry
June 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
June 30, 2026
June 1, 2026
12 months
June 24, 2026
June 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Feasibility of recruitment, retention and attendance
Feasibility will be evaluated by: recruitment rate (number of eligible patients enrolled / number of eligible patients approached), proportion of participants initiating treatment, and retention rate (number and percentage of participants completing the 16-week program). These indicators will be extracted from clinic and study records.
From study start to end of 16-week treatment program (approximately 6-9 months, depending on recruitment period)
Participant-reported acceptability and tolerability of the integrated DBR and group intervention
Acceptability and tolerability will be assessed with qualitative data from post-treatment focus group interviews (thematic analysis of perceived benefits, burdens, and suggestions for improvement).
Post-treatment (immediately after the 16-week program)
Secondary Outcomes (5)
Change in PTSD symptoms (PCL-5)
Baseline (pre-treatment), post-treatment (16 weeks), and 6-month follow-up
Change in dissociative symptoms (DES)
Baseline, post-treatment (16 weeks), and 6-month follow-up
Change in general psychological distress and functioning (CORE-OM)
Baseline, post-treatment (16 weeks), and 6-month follow-up
Change in orienting and self-awareness (Where Self Awareness Scale)
Baseline, during treatment (e.g., weekly or at predefined intervals), post-treatment, and 6-month follow-up
Change in shock-related vigilance (Shock Induced Vigilance Scale)
Baseline, during treatment (e.g., weekly or at predefined intervals), post-treatment, and 6-month follow-up
Study Arms (1)
Integrated DBR plus Supportive Group Intervention
EXPERIMENTALParticipants receive a 16-week integrated treatment program combining individual Deep Brain Reorienting (DBR) with a supportive group intervention. The program includes 1-3 preparatory individual sessions, two initial in-person psychoeducational group meetings, 16 weekly individual DBR sessions (45 minutes), and two brief digital group meetings per week focused on orienting practice ("Where Self") and integration of DBR experiences. After treatment, participants attend a focus group interview and complete follow-up assessments at post-treatment and 6 months.
Interventions
Participants receive 1-3 preparatory individual sessions for assessment, psychoeducation about Deep Brain Reorienting (DBR), and demonstration of the method, followed by 16 weekly individual DBR sessions (45 minutes each) delivered by DBR-trained therapists. DBR is a trauma-focused psychotherapy that targets the orienting and shock responses linked to threatening or attachment-related experiences, using present-moment orienting as an anchor to process subcortical shock responses without necessarily activating full trauma memories.
Participants attend two initial in-person group sessions providing psychoeducation about DBR, introduction and practice of the "Where Self" orienting exercise, and establishment of a safe group climate. During the 16-week program, participants attend two brief digital group meetings per week: one to identify a focus or trigger for the upcoming individual DBR session and practice "Where Self", and one to further adapt "Where Self" and reflect on experiences and new perspectives from DBR processing. After the 16-week program and at 6-month follow-up, participants also attend focus group interviews to discuss their experiences of the combined DBR and group intervention.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- Meets criteria for complex dissociative disorder (DID or OSDD; e.g. F44.88/F44.81)
- Referred to the Trauma Outpatient Clinic
- Own motivation to participate in the DBR intervention and the associated group program
You may not qualify if:
- Ongoing severe substance abuse
- Violent behavior
- Severe current crisis
- Ongoing high risk of suicide
- Psychotic disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Modum Badlead
Study Sites (1)
Modum Bad, Out patient Trauma clinic
Oslo, Oslo, 0251, Norway
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
KariAnne Vrabel, Professor
Modum Bad; Reseach Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 24, 2026
First Posted
June 30, 2026
Study Start
May 4, 2026
Primary Completion (Estimated)
May 1, 2027
Study Completion (Estimated)
June 1, 2027
Last Updated
June 30, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Data sharing is not planned and is regulated by the the ethics approval from The Regional Committees for Medical and Health Research Ethics (REK). Anonymized data will be made available upon reasonable request.